Psoriasis
Conditions
Interventions
Control group:Placebo
Sponsors
The Second Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Diagnosed as psoriasis vulgaris; 2. Mild to moderate psoriasis vulgaris, PASI = 18 years, female or male; 4. Female subjects of reproductive age maintained contraception during the trial through condoms, birth control pills, ligation or other contraception methods; 5. The patient is informed of the trial and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Received biologicals treatment within 6 months; 2. Received systemic glucocorticoid or immunosuppressant treatment; 3. Patients with severe gastrointestinal diseases or chronic diarrhea; 4. Received systemic antibiotic treatment within one month; 5. Patients participated in other clinical trials within one month; 6. Pregnant women or breast feeding women; 7. Disagree to use Bacteroides fragilis BF839 treatment; 8. Patients are involving in other trials now or considered as unsuitable for the trial by the trial investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PASI (Psoriasis Area and Severity Index); | — |
Secondary
| Measure | Time frame |
|---|---|
| NAPSI (Nail Psoriasis Severity Index);BSA (Body Surface Area);DLQI (Dermatology Life Quality Index));Stool intestinal flora examination; | — |
Countries
China
Contacts
Public ContactYang Wenlin
The Second Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed